Journal article
Assessing the potency of oral polio vaccine kept outside of the coldchain
This study is the first systematic documentation of the potency of monovalent oral polio vaccine type 3 (mOPV3) kept at ambient temperatures during a polio immunization campaign in Chad. During the study test vials were exposed to temperatures of up to 47.1 °C, and kept outside of the 2–8 °C range for a maximum of 86.9 hours. Post-campaign laboratory testing confirmed that the test vials were still potent, and in conformity with the defined release specifications. Further, the Vaccine Vial Monitors performed as expected, giving an early warning indication of when cumulative exposure to heat reached levels that may have negatively affected the vaccine\'s potency. This study provides proof-of-concept evidence that certain types of OPV remain potent and thus can be kept, for limited periods of time, as well as administered at ambient temperatures.
Authors
Languages
- English
Publication year
2011
Journal
Vaccine
Volume
34
Type
Journal article
Categories
- Supply chain & logistics
Diseases
- Polio
Countries
- Chad
Tags
- OPV
- VVM
- Wastage
WHO Regions
- African Region
Topic references
VVM-CTC
Title | Author | Year | Type | Language |
---|---|---|---|---|
Assessing the potency of oral polio vaccine kept outside of the coldchain | Simona Zipursky et al. | 2011 | Journal article | English |
Benefits of using vaccines out of the cold chain: Delivering Meningitis A vaccine in a controlled temperature chain during the mass immunization campaign in Benin | Simona Zipursky, Mamoudou Harouna Djingarey, Jean-Claude Lodjo, Laifoya Olodo, Sylvestre Tiendrebeogo, Olivier Ronveaux | 2014 | Journal article | English |
Extending supply chains and improving immunization coverage and equity through controlled temperature chain use of vaccines | Raja Rao, Debra Kristensen, Anna-Lea Kahn | 2017 | Journal article | English |
Vaccines beyond the cold chain - Simona Zipursky | EPELA, World Health Organization (WHO) | 2013 | Guidance | English |